Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up

BACKGROUND: The aim of this study was to evaluate long-term efficacy and survival prognostic factors of stereotactic body radiation therapy (SBRT) for un-resectable liver metastases in patients enrolled in a prospective phase II trial. METHODS AND MATERIALS: 5-year local control (LC), overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Scorsetti, Marta, Comito, Tiziana, Clerici, Elena, Franzese, Ciro, Tozzi, Angelo, Iftode, Cristina, Di Brina, Lucia, Navarria, Pierina, Mancosu, Pietro, Reggiori, Giacomo, Fogliata, Antonella, Tomatis, Stefano, Torzilli, Guido, Cozzi, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258482/
https://www.ncbi.nlm.nih.gov/pubmed/30477560
http://dx.doi.org/10.1186/s13014-018-1185-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258482/
https://www.ncbi.nlm.nih.gov/pubmed/30477560
http://dx.doi.org/10.1186/s13014-018-1185-9

Ejemplares similares